This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: St. Jude Children's Research Hospital. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Scott E. Strome: Innovator in Cancer Treatment
Introduction
Scott E. Strome is a prominent inventor based in Memphis, TN (US). He has made significant contributions to the field of medical research, particularly in cancer treatment. His innovative work has led to the development of a patent that addresses a critical health issue.
Latest Patents
Scott E. Strome holds a patent for a T-Cell Receptor designed for treating Fibrolamellar Hepatocellular Carcinoma. This invention represents a breakthrough in targeted cancer therapies, offering hope for patients suffering from this rare form of liver cancer.
Career Highlights
Strome is affiliated with St. Jude Children's Research Hospital, where he conducts his research. His work at this esteemed institution has allowed him to focus on developing advanced treatment options for pediatric patients facing cancer.
Collaborations
Throughout his career, Scott has collaborated with notable colleagues, including Paul Thomas and Jeremy Crawford. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer treatments.
Conclusion
Scott E. Strome's contributions to cancer research and treatment exemplify the impact of innovation in medicine. His patent for a T-Cell Receptor showcases his commitment to improving patient outcomes and advancing the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile